Currency in USD
| Earnings estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
|---|
| No. of analysts | 0 | 0 | 0 | 0 |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low estimate | 0 | 0 | 0 | 0 |
| High estimate | 0 | 0 | 0 | 0 |
| Year ago EPS | -0.16 | -0.15 | N/A | N/A |
| Revenue estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
|---|
| No. of analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | N/A | N/A | N/A | N/A |
| Low estimate | N/A | N/A | N/A | N/A |
| High estimate | N/A | N/A | N/A | N/A |
| Year ago sales | N/A | N/A | N/A | N/A |
| Sales growth (year/est) | N/A | N/A | N/A | N/A |
| Earnings history | 30/12/2022 | 30/03/2023 | 29/06/2023 | 29/09/2023 |
|---|
| Est. EPS | -0.16 | -0.16 | -0.15 | -0.12 |
| Actual EPS | -0.16 | -0.15 | -0.11 | -0.1 |
| Difference | 0 | 0.01 | 0.04 | 0.02 |
| Surprise % | 0.00% | 6.30% | 26.70% | 16.70% |
| EPS trend | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
|---|
| Current estimate | 0 | 0 | 0 | 0 |
| 7 days ago | -0.1 | -0.1 | -0.46 | -0.38 |
| 30 days ago | -0.1 | -0.1 | -0.46 | -0.38 |
| 60 days ago | -0.1 | -0.1 | -0.46 | -0.38 |
| 90 days ago | -0.1 | -0.1 | -0.46 | -0.38 |
| EPS revisions | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2023) | Next year (2024) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | VAXX | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | N/A | N/A | N/A | N/A |
| Next qtr. | N/A | N/A | N/A | N/A |
| Current year | N/A | N/A | N/A | N/A |
| Next year | N/A | N/A | N/A | N/A |
| Next 5 years (per annum) | -51.60% | N/A | N/A | N/A |
| Past 5 years (per annum) | N/A | N/A | N/A | N/A |
